Cargando…
Repurposing of Medicines in the EU: Launch of a Pilot Framework
Repurposing of authorised medicines has been under discussion for a long time. Drug repurposing is the process of identifying a new use for an existing medicine in an indication outside the scope of the original approved indication. Indeed, the COVID-19 health crisis has brought the concept to the f...
Autores principales: | Asker-Hagelberg, Charlotte, Boran, Tomas, Bouygues, Christelle, Eskola, Sini Marika, Helmle, Laszlo, Hernández, César, Houýez, François, Lee, Helen, Lingri, Dimitra D., Louette, Laurent, Meheus, Lydie, Penninckx, Wim, Stepniewska, Beata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784735/ https://www.ncbi.nlm.nih.gov/pubmed/35083258 http://dx.doi.org/10.3389/fmed.2021.817663 |
Ejemplares similares
-
The Repurposing Drugs in Oncology (ReDO) Project
por: Pantziarka, Pan, et al.
Publicado: (2014) -
On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
por: Verbaanderd, Ciska, et al.
Publicado: (2020) -
Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014) -
Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2015) -
Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)